Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM) News Today C$0.28 -0.02 (-6.56%) (As of 02/5/2020) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Phio Pharmaceuticals Corp.September 14, 2024 | wsj.comZomedica Corp. (ZOM) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comZomedica Corp. (AMEX:ZOM) Q1 2024 Earnings Call TranscriptMay 10, 2024 | msn.comZomedica Corp Ordinary Shares ZOMNovember 19, 2023 | morningstar.comZomedica Stock (AMEX:ZOM), DividendsMay 10, 2023 | benzinga.comZomedica acquires Structured Monitoring ProductsMay 8, 2023 | msn.comZomedica expands topline thanks to acquisitions and organic growthMarch 15, 2023 | seekingalpha.comSquarex Pharmaceutical Seeks IPO For Development FundingJanuary 25, 2023 | seekingalpha.comAdvanced Therapy Medicinal Products Market Detailed Analysis of Current Scenario with Growth Forecasts to 2029January 19, 2023 | marketwatch.comPulmonary Edema Treatment Market Opportunities, Demand and Forecasts 2023-2028 with Top Countries DataJanuary 15, 2023 | marketwatch.comCorporate Reputation of Pharma in United States, 2021-2022: The Patient Perspective of 40+ Companies 2021 v. 2020January 9, 2023 | benzinga.comHPGC Renmintongtai Pharmaceutical Corp. ADecember 14, 2022 | wsj.comRespiratory Devices Market 2023 To Garner Overwhelming Hike In Revenues by 2026 | 132 Pages ReportDecember 14, 2022 | marketwatch.comCVS Health raises annual profit forecast on strength in PBM, insurance unitsNovember 2, 2022 | msn.comMicrobion Corporation Announces Granting of a US Patent for a Pharmaceutical Composition of PravibismaneOctober 6, 2022 | yahoo.com001067F.KSOctober 1, 2022 | reuters.comSaudi Pharmaceutical Industries & Medical Appliances Corp.September 30, 2022 | wsj.comNova Mentis Completes Production of Psilocybin Microdose CapsulesSeptember 15, 2022 | finance.yahoo.comGlobal Counterfeit Drug Detection Devices Market Valuation to Exceed $1.3 Billion by 2026September 7, 2022 | finance.yahoo.comCipla receives USFDA approval for generic version of Revlimid® (Lenalidomide capsules)September 7, 2022 | finance.yahoo.comEupraxia Pharmaceuticals Reports Second Quarter 2022 Financial ResultsAugust 12, 2022 | finance.yahoo.comPsychedelic Drugs Global Market to Reach $7.03 Billion by 2026August 8, 2022 | benzinga.comInsights on the Veterinary Medicine Global Market to 2027 - by Product, Animal Type, Route of Administration, Distribution Channel and RegionJuly 15, 2022 | finance.yahoo.comDilated Cardiomyopathy Market to Boost at a CAGR of approximately 13% by 2032 | DelveInsightJuly 11, 2022 | finance.yahoo.comGlobal Decentralized Clinical Trials Market is projected to grow at a CAGR of 6.95% By 2032: Visiongain Reports LtdJune 29, 2022 | finance.yahoo.comThe Worldwide Pharmacovigilance Industry is Expected to Reach $15.8 Billion by 2030 - ResearchAndMarkets.comJune 10, 2022 | apnews.comAnnapolis Area Job Openings: Check Out The LatestApril 8, 2022 | msn.comPacerPro Director of Design Releases First in a Series of New Product EnhancementsFebruary 20, 2022 | nz.finance.yahoo.comWhy Zomedica Stock Soared 72.4% This WeekFebruary 17, 2022 | msn.comLiverpool dealt fresh injury concern ahead of Champions League meeting with Atletico MadridNovember 1, 2021 | sg.finance.yahoo.comAntarctic glacier named after Glasgow as Cop26 beginsNovember 1, 2021 | uk.finance.yahoo.com Get Zomedica Pharmaceuticals Corp. (ZOM.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). ZOM Media Mentions By Week ZOM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZOM News Sentiment▼0.000.43▲Average Medical News Sentiment ZOM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZOM Articles This Week▼00▲ZOM Articles Average Week Get Zomedica Pharmaceuticals Corp. (ZOM.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GPH News Today EQ News Today CXF News Today ME News Today BRM News Today CGC News Today RGC News Today AEZS News Today ASND News Today NBY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:ZOM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zomedica Pharmaceuticals Corp. (ZOM.V) Please log in to your account or sign up in order to add this asset to your watchlist. Share Zomedica Pharmaceuticals Corp. (ZOM.V) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
